ENDRA Life Sciences Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ENDRA Life Sciences Inc., a Delaware corporation and emerging growth company, on April 3, 2020. The report covers events occurring on March 31, 2020. The company's common stock (NDRA) and warrants (NDRAW) are listed on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an administrative filing and does not contain financial statements or performance metrics.
Material Changes
Effective March 31, 2020, the company replaced its transfer agent and registrar. VStock Transfer, LLC (VStock) replaced Corporate Stock Transfer, Inc. for the common stock and publicly traded warrants of ENDRA Life Sciences Inc.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the administrative change noted above.
Key Facts for Investors to Verify
- Confirmation that VStock Transfer, LLC is now the official transfer agent and registrar.
- Contact details for the new transfer agent: 18 Lafayette Place, Woodmere, NY 11598; (212) 828-8436.
- Verification that the change in transfer agent does not impact the trading status of NDRA or NDRAW on Nasdaq.